As per corporate shareholdings filed for Jul-2025, people matching Patient Square Capital publicly holds 21 stocks with a net worth of over US$ 344.6 M.
These are shares held by Patient Square Capital as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| Eargo Inc | Patient Square Capital | 0.00 | 15,821,299 | 76.20% | 0.00 | - | ||
| Intra-Cellular Therapies Inc | Patient Square Capital | 131.87 | 71,990 | 0.07% | 0.00 | 9.5 M | ||
| Blueprint Medicines Corp | Patient Square Capital | 129.46 | 38,500 | 0.06% | 0.00 | 5.0 M | ||
| Agios Pharmaceuticals Inc | Patient Square Capital | 38.26 | 139,732 | 0.24% | 0.00 | 5.3 M | ||
| Allogene Therapeutics Inc | Patient Square Capital | 1.14 | 2,635,000 | 1.20% | 0.11 | 3.0 M | ||
| Argen X SE - ADR | Patient Square Capital | 700.69 | 29,000 | 0.05% | NEW | 20.3 M | ||
| Cidara Therapeutics Inc | Patient Square Capital | 63.20 | 15,000 | 0.06% | NEW | 948 K | ||
| Cullinan Oncology Inc | Patient Square Capital | 7.68 | 868,897 | 1.47% | -0.02 | 6.7 M | ||
| Enliven Therapeutics Inc | Patient Square Capital | 20.70 | 245,838 | 0.42% | -0.02 | 5.1 M | ||
| EyePoint Pharmaceuticals Inc | Patient Square Capital | 11.90 | 1,352,837 | 1.96% | -0.19 | 16.1 M | ||
| Geron Corp. | Patient Square Capital | 1.48 | 716,000 | 0.11% | NEW | 1.1 M | ||
| Insmed Inc | Patient Square Capital | 143.42 | 358,800 | 0.17% | 0.01 | 51.5 M | ||
| Disc Medicine Inc | Patient Square Capital | 59.73 | 74,000 | 0.21% | -0.03 | 4.4 M | ||
| Kymera Therapeutics Inc | Patient Square Capital | 40.30 | 140,000 | 0.20% | 0.00 | 5.6 M | ||
| Liquidia Corp | Patient Square Capital | 28.56 | 1,020,000 | 1.19% | -0.59 | 29.1 M | ||
| Mirum Pharmaceuticals Inc | Patient Square Capital | 74.42 | 113,462 | 0.23% | -0.01 | 8.4 M | ||
| Nurix Therapeutics Inc | Patient Square Capital | 9.24 | 412,296 | 0.54% | -0.05 | 3.8 M | ||
| Ocular Therapeutix Inc | Patient Square Capital | 12.59 | 817,699 | 0.47% | -0.06 | 10.3 M | ||
| Roivant Sciences Ltd | Patient Square Capital | 12.28 | 12,480,000 | 1.83% | 0.00 | 153.3 M | ||
| Scholar Rock Holding Corp | Patient Square Capital | 32.88 | 154,000 | 0.16% | 0.00 | 5.1 M | ||
| VYNE Therapeutics Inc | Patient Square Capital | 0.33 | 317,033 | 1.60% | 0.06 | 104.6 K | ||
| Intellia Therapeutics Inc | 11.48 | - | Investor holds below 1% | |||||
| Soleno Therapeutics Inc | 67.74 | - | Investor holds below 1% |